Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713150 · ClinicalTrials.gov registry record
HEALthy Brain and Child Development Study - COVID-19 Supplement
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 62
- Enrollment target
NCT04713150: Completed study, sponsored by Boston Children's Hospital.
NCT04713150 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04713150 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic and will work to better support these families and children as they grow.
Primary Outcome
Using the Perceived Stress Scale (scores can range from 0 to 40, with higher scores indicating greater stress).
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2023-09-14 |
What the finished NCT04713150 record still lists
NCT04713150 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT04713150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04713150 about?
NCT04713150 is a clinical study titled "HEALthy Brain and Child Development Study - COVID-19 Supplement". The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic ...
What is the current status of trial NCT04713150?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2020-10-05. Estimated completion is 2023-09-14.
What interventions are being tested in trial NCT04713150?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT04713150?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI